These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37121335)

  • 1. MicroRNA-511-3p regulates Aβ
    Wang T; Zhao W; Liu Y; Yang D; He G; Wang Z
    Exp Gerontol; 2023 Jul; 178():112195. PubMed ID: 37121335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of miR-331-3p through improved cell viability and inflammatory marker expression: Correlation of serum miR-331-3p levels with diagnosis and severity of Alzheimer's disease.
    Liu Q; Lei C
    Exp Gerontol; 2021 Feb; 144():111187. PubMed ID: 33279668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3.
    Yu L; Li H; Liu W; Zhang L; Tian Q; Li H; Li M
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1548. PubMed ID: 33220166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-β induced neurotoxicity by targeting PTEN.
    Cao F; Liu Z; Sun G
    Exp Gerontol; 2020 Feb; 130():110814. PubMed ID: 31857133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Expression of miR-381-3p in Alzheimer's Disease Patients and Its Role in Beta-Amyloid-Induced Neurotoxicity and Inflammation.
    Zhang M; Liu Y; Teng P; Yang Q
    Neuroimmunomodulation; 2022; 29(3):211-219. PubMed ID: 34749366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer disease].
    He L; Zhang C; Wang J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):207-212. PubMed ID: 38595235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of miR-148a-3p in Alzheimer's disease and its protective role against amyloid-β induced neurotoxicity.
    Zhang H; Liu W; Ge H; Li K
    Neurosci Lett; 2021 Jun; 756():135953. PubMed ID: 33979697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
    Kumar S; Vijayan M; Reddy PH
    Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer's disease.
    He L; Chen Z; Wang J; Feng H
    BMC Neurol; 2022 Jun; 22(1):203. PubMed ID: 35659599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Discovery of MicroRNA-455-3p in Alzheimer's Disease.
    Kumar S; Reddy PH
    J Alzheimers Dis; 2019; 72(s1):S117-S130. PubMed ID: 31524168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum aberrant expression of miR-24-3p and its diagnostic value in Alzheimer's disease.
    Liu L; Liu L; Lu Y; Zhang T; Zhao W
    Biomark Med; 2021 Nov; 15(16):1499-1507. PubMed ID: 34668391
    [No Abstract]   [Full Text] [Related]  

  • 12. The microRNA-485-3p concentration in salivary exosome-enriched extracellular vesicles is related to amyloid β deposition in the brain of patients with Alzheimer's disease.
    Ryu IS; Kim DH; Ro JY; Park BG; Kim SH; Im JY; Lee JY; Yoon SJ; Kang H; Iwatsubo T; Teunissen CE; Cho HJ; Ryu JH
    Clin Biochem; 2023 Aug; 118():110603. PubMed ID: 37355215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
    Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
    Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise Protects Against Cognitive Injury and Inflammation in Alzheimer's Disease Through Elevating miR-148a-3p.
    Chen J; Bai X; Wu Q; Chen L; Wang H; Zhang J
    Neuroscience; 2023 Mar; 513():126-133. PubMed ID: 36681141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
    Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
    Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's Patients.
    Mancuso R; Agostini S; Hernis A; Zanzottera M; Bianchi A; Clerici M
    Sci Rep; 2019 Jun; 9(1):9393. PubMed ID: 31253822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircLPAR1/miR-212-3p/ZNF217 feedback loop promotes amyloid β-induced neuronal injury in Alzheimer's Disease.
    Wu L; Du Q; Wu C
    Brain Res; 2021 Nov; 1770():147622. PubMed ID: 34403662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of miR-433 in the diagnosis of Alzheimer's disease and its effect on Aβ-induced neurotoxicity by regulating JAK2.
    Wang R; Zhang J
    Exp Gerontol; 2020 Nov; 141():111080. PubMed ID: 32871216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA SNHG1 Knockdown Alleviates Amyloid-β-Induced Neuronal Injury by Regulating ZNF217 via Sponging miR-361-3p in Alzheimer's Disease.
    Gao Y; Zhang N; Lv C; Li N; Li X; Li W
    J Alzheimers Dis; 2020; 77(1):85-98. PubMed ID: 32741808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0049472 regulates the damage of Aβ-induced SK-N-SH and CHP-212 cells by mediating the miR-107/KIF1B axis.
    Zeng C; Xing H; Chen M; Chen L; Li P; Wu X; Li L
    Exp Brain Res; 2022 Sep; 240(9):2299-2309. PubMed ID: 35881155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.